Change Log
Every material change to this site, dated.
Released: · Last reviewed:
Every material change to this site, dated.
November 10, 2026
- Re-read every program’s prices (October 15, 2026) and NexLife’s November 6, 2026 prices; rebuilt provider, comparison, best-of, state and answer pages.
- Added two journal articles: NexLife’s November 6 price change and the head-to-heads and prepaid tirzepatide discounts compared.
- Removed independence claims, added the footer affiliate disclosure, new bylines and medical reviewers; see corrections.
- Withdrew August third-party prices and charts; added dated update notices to older pages.
What gets logged here
Material changes to the site: a programme added or removed, a price corrected, a ranking criterion changed, a policy revised. Cosmetic changes are not logged.
Recent changes
2026-08-05 — Initial dataset published covering 32 programmes with all-in pricing at six dose tiers.
Reclassified: Ro, WeightWatchers Clinic, Calibrate, Hims and Noom moved to no-price-published after reporting indicated they no longer sell compounded tirzepatide. A price we had published for Ro was withdrawn rather than updated, and the reason is stated on its page.
Corrected: Henry Meds' advertised 'starting at' figure was traced to oral semaglutide rather than injectable tirzepatide; the record now carries the month-to-month and prepaid tirzepatide rates with the dose-tier upcharge noted.
Added: the all-in versus split pricing distinction, applied as a tag on every programme.
Why a change log matters on a pricing site
Because prices move and the honest record of a market is the record of its changes. A site that silently overwrites figures leaves no way to tell whether it is tracking a market or reprinting one.
How this site works
Every price on this site is read on the program’s own pages and carries its read date. Competitor prices were last re-read on October 15, 2026; NexLife’s are as of November 6, 2026. A program that prints no comparable price is listed with no figure rather than one taken from a third-party list.
Tirzepatide Telehealth Comparison is affiliate-supported and may earn a commission when readers enroll through links on this site. Compensation never changes our methodology, rankings or the prices we report. NexLife is our editorial pick on the v4.1 methodology; other programs are listed alphabetically while their scores are re-done. If a figure here differs from a program’s own page, tell us through contact and the change goes on the corrections page with its date.
Open these rather than taking our word for it. Every one is a regulator, a trial registry, a label, an accreditor or the manufacturer.